share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股SEC公告 ·  05/31 10:58
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,250 shares of common stock on 05/31/2024, with an aggregate market value of approximately $1,001,250. The shares were acquired through restricted stock vesting as part of compensation on two separate occasions, with 1,422 shares vested on 02/17/2024 and an additional 828 shares on 02/24/2024, both from the issuer. This planned sale follows a recent transaction history where Tatsis sold 2,350 shares for a total gross proceed of $1,031,908.5 over the past three months.
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,250 shares of common stock on 05/31/2024, with an aggregate market value of approximately $1,001,250. The shares were acquired through restricted stock vesting as part of compensation on two separate occasions, with 1,422 shares vested on 02/17/2024 and an additional 828 shares on 02/24/2024, both from the issuer. This planned sale follows a recent transaction history where Tatsis sold 2,350 shares for a total gross proceed of $1,031,908.5 over the past three months.
Vertex Pharmicals Inc.高管欧拉尼亚·塔西斯定于2024年5月31日出售2,250股普通股,总市值约为1,001,250美元。这些股票是通过限制性股票归属作为补偿的一部分在两个不同的场合收购的,其中1,422股于2024年2月17日归属,2024年2月24日又收购了828股,均来自发行人。此次计划出售遵循了最近的交易记录,塔西斯在过去三个月中出售了2350股股票,总收益为1,031,908.5美元。
Vertex Pharmicals Inc.高管欧拉尼亚·塔西斯定于2024年5月31日出售2,250股普通股,总市值约为1,001,250美元。这些股票是通过限制性股票归属作为补偿的一部分在两个不同的场合收购的,其中1,422股于2024年2月17日归属,2024年2月24日又收购了828股,均来自发行人。此次计划出售遵循了最近的交易记录,塔西斯在过去三个月中出售了2350股股票,总收益为1,031,908.5美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息